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• The linear growth of 29 patients was 
evaluated from two to 4"" YNfS after liver 
transplantation. All patlem.1'8C8lved cy-
closporlne and low-do.e prednisone. 
Eight patients (28%) dlsphlyed accelera-
tion of linear growth velocity and were 
above the fifth percentile at the end of 
the evaluation period. Four patients 
(14%) grew normally prior to transplanta-
tion and continued to grow normally 
after the surgical procedute. Only four 
patients (14%) dropped tram higher lev-
els to below the fifth percentUe. thirteen 
patients (45%) were Ie .. than the fifth 
percentile before and after surgery; ten 
otthese13 patients have attained normal 
or accelerated growth velocity. Good lin-
ear growth has been achleved In more 
than three fourths of patients who under-
went liver transplantation. 
(AJDC 1987;141 :547-549) 
r,rear growth failure commonly oc-
curs in children with end-stage 
liver disease, including chlldren who 
have received an otherwise "success-
ful" portoenterostomy.l In this study, 
we examined linear growth in 29 pedi-
. atric patients who had undergone 
j.
:!orth ... '.:.... otopic liver transplantation. 
" 
n: PATIENTS AND METHODS 
: y~ Patient Population 
· TForty-nine pediatric patients underwent 
:iOl"thotopic liver transplamation between 
, .. )lay 1, 1981, and June 1, 1983. Thirty-two ~nts (65.3%) survived toJan 1,1986; one 
,",)iatient subsequently died. Epiphyses had 
:~y closed in three of the survivors at 
;the time of their surgery; 'consequently, 
these patients were not included in the 
Aeeepted for publication Oet 16, 1986. 
From the Departments of Pedittries (Drs U r-
bleb, Gartner, Malatsck, and Zitelli) and Sur· 
IVy (Drs lwatsuki, Shaw, aIIII Starz)), Univer-
~ 01 Pittsburgh Health Ceater and Children's K~tal of Pittsburgh. 
£K~rint requests to Derw-t-t «Pediatrics, 
r:KDK~ ... " n's Hospital of PittstlarP, One Children's · , 8706 Fifth Ave at DeSato St, Pittsburgh, ;16218-3417 (Dr Urbach). ~ ;I~: 
· Vol 141 , May 1987 
-,-,' 
study. The remaining 29 patients (18 female 
and 11 male patients) were included. 
The indications for transplantation were 
biliary atresia (13 patients), biliary hypo-
plasia (one patient), metabolic disease (ten 
patients), familial cholestasis (three pa-
tients), neonatal hepatitis (one patient), 
and benign liver tumor (one patient). Six 
patients received two transplants and one 
patient received three transplants. The 
ages of the patients at the time of trans-
plantation ranged from 7 months to 13 years 
(average, 5.2 years). Twenty-eight of the 29 
patients were less than 10.5 years of age. 
All patients were Tanner stage I (pre-
pubertal) at the time of surgery. 
Immunosuppression Regimen 
Cyclosporine and prednisone2.3 were ad-
ministered in doses that were tapered as 
quickly as was consistent with avoidance of 
rejection.'·6 Patients received 2.5 to 5 mg of 
prednisone as a single daily dose and an 
average dosage of 9.4 mg/kg/d of cyclo-
sporine (range, 4.6 to 20 mg/kg/d) divided 
twice daily. Whole blood cyclosporine levels 
were measured by high-perfonnance liquid 
chromatographt with maintenance of 
trough levels between 100 to 350 ng/mL (83 
to 291 nmollL). 
Twenty-five patients had been receiving 
2.5 to 6.0 mgld of prednisone for an average 
of 30.3 months. At their last evaluation, 
only four patients received more than 
5 mgld of prednisone. Three of these pa-
tients currently suffer from mild chronic 
rejection. The fourth patient continues to 
have elevated levels of serum trans-
aminases secondary to recurrent neuro-
visceral storage disease with supranuclear 
ophthalmoplegia.7 The average daily dos-
age of prednisone for all 29 patients was 
0.21 mg/kg/d given as a single morning 
dose. 
Growth Measurements 
Pretransplantation data were gathered 
from growth records of primary physicians 
and from measurements made during the 
preoperative evaluation at the Children's 
Hospital of Pittsburgh. Postoperative 
growth data were collected during follow-
up visits to our unit as well as to primary 
referring physicians. All but two patients 
returned regularly to our clinic for follow-
up evaluations. The eight patients less than 
3 years of age at the time of surgery were 
measured with a fiberglass tape measure in 
the supine position while older children 
were measured standing on a conventional 
metal scale. All patients were barefooted, 
when measured. All measurements r.e': 
corded after July 1985 at the Children's 
Hospital of Pittsburgh were obtained with 
a Harpenden stadiometer. To assess the 
correlation between the metal scale and 
stadiometer, we measured 20 children after 
transplantation using both methods. We 
failed to find any statistically significant 
difference between these two methods by 
both parametric and nonparametric tests 
(P> .10; correlation, .99). 
For those children whose preoperative 
and postoperative growth lengths plotted 
below the fifth percentile on the cumulative 
chart of the National Center of Health 
Statistics, linear growth velocity was calcu-
lated and plotted on the charts created by 
Tanner and Whitehouse for this purpose, 8 
The intervals between the first and last 
measurements postoperatively ranged 
from 24 to 52 months. The average length of 
postoperative follow-up was 35.8 months. 
RESULTS 
Lack of growth was consistently ob-
served in the six- to 12-month period 
following transplantation. During this 
interval, patients required multiple 
surgical procedures and had nutri-
tional requirements that could not al-
ways be met adequately. As a rule, the 
general health of surviving patients 
improved with time.' The growth 
curves of 29 patients were evaluated 
for at least two years after orthotopic 
liver transplantation (Fig 1). Eight 
(four female and four male patients) 
(28%) of 29 patients displayed acceler-
ated growth velocity and were above 
the fifth percentile at the end of the 
evaluation period (Table). Four other 
patients (14%) had normal height prior 
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Fig 1. -Summary of linear growth data of 29 
patients who underwent liver transplanta-
tion. In four patients (closed circles), per-
centiles remained same as before trans-
plantation and are above the fifth percentile. 
Eight patients (open circles) crossed per-
centiles in upward direction and are above 
the fifth percentile. Four patients (open tri-
angles) crossed percentiles in downward 
direction and dropped below the fifth per-
centile. Shaded area in lower left corner 
represents 13 patients whose height before 
and after transplantation was less than the 
fifth percentile. Growth velocity curves of 
these last patients are considered further in 
Fig 2. 
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to transplantation and maintained nor-
mal growth velocity following trans-
plantation. Thus, 12 patients (41%) at-
tained both height above the fifth 
percentile and normal or accelerated 
growth velocity two years or more 
postoperatively. Thirteen patients 
(45%) were less than the fifth percen-
tile for height or length both before 
and after transplantation, but most of 
these patients experienced good linear 
growth postoperatively (Fig 2). 
Four patients (14%) were above the 
fifth percentile preoperatively but 
dropped to below the fifth percentile 
following surgery (Table). Of these pa-
tients, one child had three transplants 
I 
and required 10 to 20 mg/d of pred2 
nisone for the year following initial 
transplantation. His growth velocity 
during the last year has been greater 
than the 95th percentile, and his linear 
growth is rapidly approaching the fifth 
percentile. One patient with hepato-
lenticular degeneration underwent 
transplantation at age 13 years; he was 
more malnourished at the time of 
transplantation than any other recipi-
ent. He weighed 44 kg before onset of 
the disease but dropped to 22 kg after 
transplantation. FUrthermore, he had 
chrrlmc renal disease. This patient did 
not grow for 18 months after liver 
transplantation, dropping from the 
r;, 
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No. (%)of 
Patients 
Total survivors 29 (100) 
Crossed percentiles in upward direction and are above the fifth percentile 8 (28) 
Normal height prior to transplantation with no percentile change 4 (14) 
less than the fifth percentile before and after transplantation 13 (45) 
Crossed percentiles in downward direction falling below the fifth percentile 4 (14) 
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Fig 2.-Left. Female growth velocity curve of ten patients whose height before and after transplantation was below 
the fifth percentile. Note that eight of these patients show normal growth velocity postoperatively. Right, Male 
growth velocity curve of three patients whose height before and after transplantation was below the fifth percentile. 
Note that two of these patients show normal growth velocity postoperatively. Curves are based on work of Tanner 
and Whitehouse as reported by Smith.' 
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25th to less than the fifth percentile for 
height. He entered puberty with a 
brief pubertal growth spurt. A third 
patient who had neurovisceral storage 
disease with supranuclear ophthalmo-
plegia 7 developed recurrent disease 
and was treated with 0.3 mg/kg/d of 
prednisone; in retrospect, we believe 
that her elevated levels of liver en-
zymes were related not to rejection 
but to recurrent disease. The last pa-
tient who experienced a drop in 
growth percentiles began at the fifth 
percentile and is now 1.5 cm below the 
fifth percentile at age 8 years. There is 
no explanation for his lack of linear 
growth. 
Thirteen (45%) of 29 patients were 
below the fifth percentile for linear 
growth prior to transplantation and 
remained below the fifth percentile 
following surgery (Fig 1, shaded area). 
Their growth velocities were plotted 
on a growth velocity curve to more 
accurately assess their growth acceler-
ation or deceleration. There were ten 
female (Fig 2, left) and three male (Fig 
2, right) patients. Eight of the ten 
female patients achieved normal 
growth velocities or accelerations 
despite remaining below the fifth per-
centile (Fig 2, left). One of the two 
patients with growth failure is 6 years 
old and has not had any episodes of 
rejection in two years; however, she is 
presently receiving 0.3 mg/kg/d of 
prednisone. The other child with 
groWth failuri is 11 years old and has 
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had a recent deceleration in growth 
velocity. The cause of her growth fail-
ure is unknown. Two of the three male 
patients attained normal growth veloc-
ity (Fig 2, right). The male child with 
growth failure has received two liver 
transplants and has required ex-
tremely high doses of prednisone 
(0.75 mg/kg/d), as well as frequent 
steroid pulse therapy, to maintain 
graft function. 
COMMENT 
Prior to the use of cyclosporine, the 
use of transplantation techniques in 
the pediatric age group was marred by 
growth retardation and a multitude of 
other complications attributable to 
high-dose corticosteroids. &-l4 With the 
use of cyclosporine, high-dose pred-
nisone therapy usually has been un-
necessary. Survival of both the patient 
and graft, as well as quality of life, 
have been improved with transplanta-
tion of kidneys and livers in adults2; 
similar improvement has been pre-
dicted for children.3 
Detailed growth studies with the 
use of cyclosporine and prednisone for 
immunosuppression pave been limited 
to kidney transplantation recipients. 
The reports of Conley et al15 and Klare 
et allIS have been optimistic, whereas 
Ellis et aP7 described poor or absent 
growth in seven of their eight kidney 
recipients. 
Our study has shown that good 
growth can be expected in pediatric 
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The critical importance of linear' 
growth for the emotional well-being 
and reintegration of the transplant pa-
tient into normal childhood activities 
has been frequently emphasized. ll.l2.15 
The data reported herein have demon-
strated regular achievement of this 
objective by liver transplantation in 
children with end-stage liver disease. 
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